References
- 1. Fatima S. et al., A review on importance of ACE inhibitors in clinical practice. Med. Res. Chron., 2014, 1 (1), 102-109.
- 2. Mancia G. et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013 Jul; 31(7): 1281-357.
- 3. Wiseman LR, McTavish D. Trandolapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in essential hypertension. Drugs 1994, 48:71-90.
- 4. Freeman R et al. Neurogenic Orthostatic Hypotension. N Engl J Med. 2008; 358:615-624
- 5. Low P et al. Prevalence of orthostatic hypotension. Clin Auton Res 2007 18[Suppl 1]:8-13.
- 6. Gupta V, Lipsitz LA Orthostatic Hypotension in the Elderly: Diagnosis and Treatment. Am J Med 2007; 120: 841-847.
- 7. Zia A, Kamaruzzaman SB, Tan MP. Blood pressure lowering therapy in older people: Does it really cause postural hypotension or falls? Postgraduate medicine. 2015; 127(2):186-93.
- 8. Shibao C et al. ASH Position Paper: Evaluation and Treatment of Orthostatic Hypotension. J Clinic Hypertension. 2013; 15(3): 147-53.
- 9. Lahrmann H et al. Orthostatic hypotension. In European Handbook of Neurological Managemen. 2011; Volume 1, 2nd Edition. 469-75.
- 10. Davy KP, Seals DR, Tanaka H. Augmented cardiopulmonary and integrative sympathetic baroreflexes but attenuated peripheral vasoconstriction with age. Hypertension. 1998;32:298-304.
- 11. Rutan GH, Hermanson B, Bild DE, et al. Orthostatic hypotension in older adults. The Cardiovascular Health Study. CHS Collaborative Research Group. Hypertension. 1992;19(6 Pt 1):508-519.10.1161/01.HYP.19.6.508
- 12. Freeman R, Wieling W, Axelrod FB, et al. Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clin Auton Res. 2011; 21: 69-72.
- 13. Fedorowski A, Stavenow L, Hedblad B, Berglund G, Nilsson PM, Melander O. Orthostatic hypotension predicts all-cause mortality and coronary events in middle- aged individuals (The Malmo¨ Preventive Project). European Heart Journal.2010; 31: 85-91.10.1093/eurheartj/ehp329
- 14. Eigenbrodt M et al. Orthostatic Hypotension as a Risk Factor for Stroke The Atherosclerosis Risk in Communities (ARIC) Study, 1987-1996. Stroke. 2000;31:2307-2313.
- 15. Kamaruzzaman S, Watt H, Carson C, Ebrahim S. The association between orthostatic hypotension and medication use in the British Women’s Heart and Health Study. Age Ageing. 2010;39:51-56.
- 16. Canney M et al. Single Agent Antihypertensive Therapy and Orthostatic Blood Pressure Behaviour in Older Adults Using Beat-to-Beat Measurements: The Irish Longitudinal Study on Ageing. PLoS ONE 11(1): e0146156. doi:10.1371.
- 17. Montastruc JL, Laborie I, Bagheri H, Senard JM. Drug- Induced Orthostatic Hypotension: A Five-Year Experience in a Regional Pharmacovigilance Centre in France Clin Drug Invest. 1997; 14(1): 61-65.10.2165/00044011-199714010-00008
- 18. Furlan et al. Chronic Orthostatic Intolerance A Disorder With Discordant Cardiac and Vascular Sympathetic Control. Circulation. 1998;98:2154-2159.10.1161/01.CIR.98.20.2154
- 19. De Ponti F, Marelli C, D’Angelo L, Caravaggi M, Bianco L, Lecchini S, Frigo GM, Crema A. Pharmacological activity and safety of trandolapril (RU 44570) in healthy volunteers. Eur J Clin Pharmacol. 1991;40(2):149-53.
- 20. Li X, Liu C, Wu M, Zhang H, Sun Y, Cheng L, Chen H, Liu C, Yang L, Zhang Q, Cao Y, Gu J, Ding Y. Pharmacokinetics, Pharmacodynamics, and Tolerability of Single and Multiple Doses of Trandolapril, an Effective Angiotensin-Converting Enzyme Inhibitor, in Healthy Chinese Subjects. Eur J Drug Metab Pharmacokinet. 2016 Aug;41(4):373-84.10.1007/s13318-015-0277-2